A new experimental and clinical approach of combining usage of highly active tumor-infiltrating lymphocytes and highly sensitive antitumor drugs for the advanced malignant tumor.

Source:http://linkedlifedata.com/resource/pubmed/id/7867384

Download in:

View as

General Info

PMID
7867384